Source Job

$190,000–$270,000/yr
US

  • Lead U.S. trade and distribution strategy for rare disease gene therapy portfolio.
  • Manage partnerships with specialty distributors, pharmacies, and third-party logistics providers.
  • Ensure launch readiness and operational excellence while collaborating cross-functionally.

Strategic Planning Vendor Management Supply Chain Data Analysis Regulatory Compliance

13 jobs similar to Director, Trade and Distribution

Jobs ranked by similarity.

$187,000–$265,000/yr

  • Develop and execute targeted engagement strategies for key accounts and treatment centers in the Central US region.
  • Lead regional business planning and collaborate with cross-functional teams to drive commercial launch readiness.
  • Serve as primary point of contact for stakeholders, ensuring alignment with corporate goals and market access strategies.

Since 2009, REGENXBIO has pioneered gene therapy, advancing a pipeline of treatments for rare and retinal diseases. Their growing, mission-driven team collaborates to develop transformative therapies for patients in need.

$245,000–$350,000/yr
US

  • Lead strategic engagement with payers, PBMs, and GPO accounts to secure patient access.
  • Develop market access strategies and negotiate contracts, including value-based models.
  • Build and oversee payer account teams while collaborating across functions.

REGENXBIO is a gene therapy company pioneering treatments for rare and retinal diseases. The company fosters a collaborative, patient-focused culture with a talented team working to make a meaningful difference for patients and their families.

US

  • Design and lead the U.S. field reimbursement team for the launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
  • Partner with payer strategy, hub vendor, and cross-functional teams to ensure compliant patient access and reimbursement.
  • Own field reimbursement SOPs, budget, and team performance while capturing insights to shape market access strategy.

Capricor Therapeutics is a biotechnology company advancing transformative cell and exosome-based therapies for rare diseases. It is a publicly traded, mission-driven organization with a collaborative culture focused on scientific rigor and execution.

US

  • Sets trade channel strategy, serves as executive relationship lead for National Retail and strategic partners, and manages day-to-day trade and distribution operations.
  • Leads trade activation, contracting, and compliance to ensure product access, inventory management, and measurable account growth.
  • Builds and directs the trade function, collaborating cross-functionally to optimize channel economics and launch readiness.

ARS Pharmaceuticals is a fast-growing, innovative company dedicated to transforming severe allergic reaction treatment with the first FDA-approved needle-free epinephrine. The culture is collaborative, entrepreneurial, and inclusive, driven by a mission to make a meaningful impact.

US

  • Lead commercial operations and analytics for the U.S. launch of deramiocel, a cell therapy for Duchenne muscular dystrophy.
  • Build and oversee commercial data ecosystem, analytics, forecasting, and field operations.
  • Establish scalable processes, governance, and cross-functional partnerships to drive launch readiness.

Capricor Therapeutics is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. The company is publicly traded and fosters a collaborative, mission-driven culture focused on innovation and patient impact.

US Unlimited PTO

  • Develop and maintain senior payer relationships across a ten-state Northeast territory.
  • Lead account strategy for 16 accounts including Highmark, Independence, Point32Health, and UPMC.
  • Coordinate cross-functionally to resolve access barriers and support rare disease launches.

BridgeBio is a biopharmaceutical company using a 'moneyball for biotech' model to advance early-stage research and develop rare disease treatments. It values curiosity, experimentation, and boundary-pushing, fostering a collaborative culture with respected industry minds.

$90,000–$110,000/yr
US

  • Execute logistics demand planning and forecast consolidation across Life Sciences and Diagnostics business units.
  • Coordinate inventory movement, distribution capacity, and import/export compliance in a regulated environment.
  • Maintain planning master data, build dashboards, and support scenario modeling for disruptions.

Beacon Biosignals is transforming precision medicine for the brain, offering at-home EEG platforms for clinical development and diagnostics. The company is growing with robust remote practices and has office hubs in Boston, New York, and Paris.

US Unlimited PTO

  • Serve as regional reimbursement expert, educating providers on access pathways and addressing barriers in commercial and government payer environments.
  • Coordinate family access and support, ensuring compliant education and seamless coordination among providers, pharmacies, and internal teams.
  • Act as a senior cross-functional partner, generating field insights and contributing to access strategy while mentoring colleagues.

BridgeBio pioneered a 'moneyball for biotech' approach, pooling early-stage research to reduce risk and unleash innovation for rare diseases. They value curiosity and experimentation, with a culture that defies convention and empowers problem-solvers.

US Unlimited PTO

  • Manage end-to-end clinical supply chain planning, execution, and oversight for cardiomyopathy programs.
  • Oversee shipping and logistics operations, including carrier management, import/export compliance, and cold-chain coordination.
  • Partner cross-functionally to align supply timelines and ensure compliant drug supply.

Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to treat cardiomyopathies. It is a small, growing company with a fast-paced, autonomous culture.

$210,000–$250,000/yr
US Unlimited PTO

  • Lead and execute access and reimbursement strategy aligned with BridgeBio objectives.
  • Manage, coach, and develop a team of Field Reimbursement Managers.
  • Serve as a senior subject matter expert on payer coverage, prior authorization, and reimbursement pathways.

BridgeBio is a biopharma company that develops life-changing medicines for rare diseases and unmet medical needs, using a 'moneyball for biotech' model to pool early-stage research. They value curiosity, experimentation, and ethical AI use, and foster a collaborative, family-focused culture.

US

  • Support clinical trial recruitment and site outreach, coordinating feedback with clinical teams.
  • Establish scientific relationships with KOLs in the Duchenne community and refine KOL mapping.
  • Gather scientific insights and attend medical conferences as a Medical Affairs representative.

REGENXBIO is a biotechnology company focused on developing novel AAV gene therapies for patients with rare diseases. The company has a collaborative culture driven by core values of trust, accountability, perseverance, and innovation.

US Unlimited PTO

  • Lead clinical supply chain activities including labeling, packaging, global distribution, inventory management, and IP reconciliation.
  • Develop and maintain supply plans aligned with clinical enrollment, dosing, regulatory timelines, and study milestones.
  • Provide operational oversight of contract organizations for packaging, labeling, and distribution.

Entrada is a clinical-stage biopharmaceutical company developing genetic medicines for neuromuscular and inherited retinal diseases. They are a tight-knit team of experts in therapeutic development and rare diseases, dedicated to improving patients' lives.

US

  • Build and lead commercial data, advanced analytics, and forecasting capabilities to support launch readiness.
  • Develop patient-based forecasts and decision-support models to guide commercial strategy.
  • Translate complex data into actionable insights and KPIs for senior executives and operating teams.

REGENXBIO is a gene therapy company advancing a pipeline of treatments for rare and retinal diseases. The culture is purpose-driven and collaborative, with a focus on making a meaningful difference for patients and their families.